<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Coagulation and fibrinolytic activities were studied in 18 subjects with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease and compared with results from 14 matched control patients suffering from sero-negative <z:hpo ids='HP_0001369'>arthritis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Significantly higher plasma concentrations (median and range) were found in <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's patients for the following variables: fibrinogen 3.7 (1.7-6.9) vs 3.0 (2.0-5.1) g/l, p less than 0.05; <z:e sem="disease" ids="C0042974" disease_type="Disease or Syndrome" abbrv="">von Willebrand</z:e> factor antigen, 115 (72-344) vs 74 (60-119)%, p less than 0.002; plasminogen activator activity (10(6)/ECLT2) 219 (94-329) vs 137 (78-197) units, p less than 0.002; tissue plasminogen activator inhibitor (t-PA-I) activity, 9.1 (5.5-19.3) vs 5.1 (1.8-12.0) IU/ml, p less than 0.002; and PAI-1 antigen, 13.9 (4.5-20.9) vs 6.4 (2.4-11.1) ng/ml, p less than 0.002 </plain></SENT>
<SENT sid="2" pm="."><plain>Protein C antigen was significiantly lower: 97 (70-183) vs 126 (96-220)%, p less than 0.02 </plain></SENT>
<SENT sid="3" pm="."><plain>No differences were observed in antithrombin III activity or antigen, factor VIII coagulant activity, fibrinopeptides A and B beta 15-42, plasminogen, alpha-2-antiplasmin, functional and immunological tissue-plasminogen activator, thrombin-antithrombin complexes and D-dimer </plain></SENT>
<SENT sid="4" pm="."><plain>Levels of tissue plasminogen activator inhibitor (activity and antigen) correlated with disease activity while fibrinogen and <z:e sem="disease" ids="C0042974" disease_type="Disease or Syndrome" abbrv="">von Willebrand</z:e> factor concentrations did not </plain></SENT>
<SENT sid="5" pm="."><plain>Seven of the 18 subjects with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease had suffered thrombotic events but it was not possible to distinguish these from the 11 patients without <z:mp ids='MP_0005048'>thrombosis</z:mp> using the assays performed </plain></SENT>
<SENT sid="6" pm="."><plain>The results suggest the abnormal fibrinolytic activity in <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease is due to increased inhibition of tissue plasminogen activator </plain></SENT>
<SENT sid="7" pm="."><plain>No <z:hpo ids='HP_0001928'>abnormality of coagulation</z:hpo> or fibrinolytic activity specific to <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease was detected </plain></SENT>
</text></document>